Medco profit hits USD 275.3 million as Medco Energi Internasional stock costs EUR 0.07
Published on 10/21/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGrowth and acquisition context
- MedcoEnergi signed the Kutei Basin agreement on October 12, 2026.
- First-half 2026 net income reached USD 275.3 million, up 796.6 percent year over year.
- Medco Energi Internasional stock trades at EUR 0.07 at 10:30 a.m. CEST at Lang & Schwarz on October 21, 2026.
Medco Energi Internasional stock costs EUR 0.07 at Lang & Schwarz on October 21, 2026, at 10:30 a.m. CEST. MedcoEnergi reported net income of USD 275.3 million for the first half of 2026, up 796.6 percent from USD 30.7 million a year earlier, according to the company's MedcoEnergi.
Profit growth strengthens the base
The first-half result combined higher output with stronger realized prices. Oil and gas production reached 170.1 thousand barrels of oil equivalent per day, 19.0 percent above the first half of 2025, while revenue rose 23.4 percent to USD 1.4147 billion.
EBITDA increased 30.7 percent to USD 805.1 million, and the EBITDA margin widened to 56.9 percent from 53.7 percent. Operating cash flow reached USD 514.7 million, a 46.6 percent year-over-year increase, while restricted-group net debt to EBITDA improved to 1.4 times from 2.0 times at the end of 2025.
What does the Kutei deal change?
On October 12, 2026, MedcoEnergi signed an agreement to acquire a 10 percent non-operating interest in four Kutei Basin production-sharing contracts from Eni. The assets cover production, development and exploration activities, and completion remains subject to regulatory approval, ANTARA reported on October 12, 2026.
Three milestones define the picture
On September 9, 2026, MedcoEnergi maintained its 2026 oil and gas production guidance at 165 to 170 thousand barrels of oil equivalent per day. On September 21, 2026, the company reported first-half net income of USD 275.3 million. The October 12, 2026, Kutei agreement added a 10 percent interest in four gas-linked contracts.
Credit risk meets expansion
Fitch maintained Medco's BB- rating with a stable outlook in a report dated October 18, 2026. Fitch projected consolidated net debt to EBITDA would rise from 2.5 times at the end of 2025 to 3.0 times in 2028, while remaining below its 3.3 times negative-rating sensitivity threshold, as Kontan reported on October 19, 2026.
Stock price and investor context
For investors, the central trade-off is clear: the Kutei assets expand MedcoEnergi's gas portfolio, while the projected leverage increase makes capital discipline important. The company's first-half production was already at the upper end of its 2026 guidance range, leaving execution and regulatory approval as the next concrete markers.
Medco Energi Internasional stock was trading at EUR 0.07 at Lang & Schwarz on October 21, 2026, at 10:30 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Medco Energi Internasional stock.
Medco Energi Internasional stock facts
- Company: PT Medco Energi Internasional Tbk
- ISIN: ID1000053705
- Ticker: MEDC
- Primary exchange: Indonesia Stock Exchange
- Price Lang & Schwarz (as of October 21, 2026, 10:30 a.m. CEST): EUR 0.07
- Market capitalization: IDR 34.6 trillion (as of October 21, 2026)
- 52-week range: IDR 1,005.00-2,000.00 (as of October 21, 2026)
- Sector / Industry: Energy / Oil and Gas Exploration and Production
Market context: Latest market reports.
